© 2020 MJH Life Sciences and Urology Times. All rights reserved.
All News
The Latest in Testosterone Replacement Therapy
June 18, 2020
How has the FDA’s mesh guidance affected POP treatment?
May 26, 2020
"I prefer doing transvaginal prolapse surgery with native tissue and always have. So I was not affected when mesh was restricted," says one urologist.
Dr. Lemack on treatments in development for OAB
May 18, 2020
In this video, Gary Lemack, MD, offers a brief overview of overactive bladder treatments in development and explains their significance for providers and patients.
MOSES-enabled pulsed laser allows same-day discharge without catheter
May 18, 2020
The benefits of holmium laser enucleation of the prostate with MOSES-enabled pulsed laser modulation justify its consideration as the gold standard surgical treatment for lower urinary tract symptoms related to benign prostatic hyperplasia, according to Amy E. Krambeck, MD.
Study adds to evidence linking anticholinergics, dementia
May 11, 2020
Patients using anticholinergic medications for the management of overactive bladder (OAB) are at increased risk of new-onset dementia compared with individuals treated with the beta-3 agonist mirabegron (Myrbetriq), according to findings of a new population-based, retrospective study published online March 13, 2020, in BJU International.
New developments may change treatment of OAB
April 21, 2020
"New treatments (pharmacological and device based) are currently in development to expand our OAB armamentarium," write Nathan Chertack, MD, and Gary Lemack, MD.
Unhealthy diet associated with poor semen quality
April 07, 2020
Unhealthy eating, like that associated with the Western diet, is associated with notably worse semen quality and less favorable testicular function than healthier eating patterns, according to a study of nearly 3,000 young Danish men published in JAMA Network Open (2020; 3:e1921610).
FDA accepts new drug application for overactive bladder agent
March 24, 2020
The FDA has accepted for review Urovant Sciences’ New Drug Application for once-daily 75 mg vibegron for the treatment of patients with overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency.
Study: Urethroplasty use on the rise
March 06, 2020
A significant trend is occurring in the management of urethral stricture, with increased utilization of urethroplasty and decreased utilization of repeat endoscopic procedures, researchers at the University of Washington in Seattle report.